Studies concerning indirect mechanisms linking GLP-1 RAs, to coronary events are not included
Diabetes, Antidiabetic Medications, and Pancreatic Cancer Risk: an Analysis from the International Pancreatic Cancer Case-Control Consortium
Final results are expected in late 2026 and could significantly expand tirzepatides FDA-approved cardiovascular indication, mirroring the SELECT breakthrough for semaglutide
Long-term benefits studied include healthspan extension, disease prevention, metabolic optimization, and biological age reduction
NAC remains effective regardless because it directly increases intracellular glutathione synthesis rather than relying on dietary intake
BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems